Table 1.

Baseline characteristics of the population (n=131).

Parameters
Age (mean +/− sd), y	71.5 +/− 15 (Median 74)
Sex	Female n=52(39%), Male n=79(61%)
History of Hypertension	92 (70%)
Admission MABP(mean +/− sd), mm Hg	113 +/− 28
Glucose (mean +/− sd), mg/dL	143.5 +/− 51.7
Glucose<= 170	69(53%)
Glucose> 170	62(47%)
Platelets (mean +/− sd), th/cumm	246 +/− 78
Anticoagulation	Yes 24(18%), No 107(82%)
INR (mean +/− sd)	1.28 +/− 0.96
Antiplatelet Medication	Yes 46(35%), No 85(65%)
Infusion of platelets on admission	Yes 12(9%)
Administration of Vitamin K on admission	Yes 19(14%)
Infusion of Fresh Frozen Plasma on admission	Yes 17(13%)
Initial ICH Volume (mean +/− sd), mL	26.1 +/− 28
Presence of IVH	48(36.6%)
Time of ED arrival to CT (mean +/− sd), h	2.1 +/− 2.8
Time of onset to followup CT(mean +/− sd), h	13.7 +/− 8.7
Admission ICH Volume (median), mL	14.9
Followup ICH volume (mean +/− sd), mL	29.2 +/− 33.6
Follow up ICH volume (median), mL	15.1
In-hospital mortality	28(21%)
Discharge mRS	3.54 +/− 1.67
Three month mRS	3.14 +/− 2.01
Average rate of ICH expansion (mean +/− sd), mL/ h	0.62 +/− 2.8
Spot sign	31 (24%)
Score 0	100 (76%)
1	14 (11%)
2	11 (8%)
3	4 (3%)
4	2 (1.5%)

Notes: MABP indicates Mean arterial blood pressure. ICH indicates Intracerebral hemorrhage. IVH indicates intraventricular hemorrhaae. SD indicates standard deviation. mRS indicates modified Rankin scale.